|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017243,
umls-concept:C0030705,
umls-concept:C0085405,
umls-concept:C0171016,
umls-concept:C0332152,
umls-concept:C0332157,
umls-concept:C0393022,
umls-concept:C0855112,
umls-concept:C1274040,
umls-concept:C1422836,
umls-concept:C1824429,
umls-concept:C2603343
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-12-3
|
|
pubmed:abstractText |
The role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
pubmed-author:AndreuRafaelR,
pubmed-author:ArnanMontserratM,
pubmed-author:CaballeroMaría-DoloresMD,
pubmed-author:CanalesMiguel AMA,
pubmed-author:CondeEulogioE,
pubmed-author:DebenGuillermoG,
pubmed-author:DonatoEva MEM,
pubmed-author:García-SanchezPedroP,
pubmed-author:González-BarcaEvaE,
pubmed-author:GonzálezJosé AJA,
pubmed-author:GrandeCarlosC,
pubmed-author:Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO...,
pubmed-author:LeónAngelA,
pubmed-author:MartínAlejandroA,
pubmed-author:NistalSaraS,
pubmed-author:RequenaMaría-JoséMJ,
pubmed-author:RuizConcepciónC,
pubmed-author:SalarAntonioA,
pubmed-author:SanchoJuan MJM,
pubmed-author:VázquezLourdesL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1829-36
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18945747-Adolescent,
pubmed-meshheading:18945747-Adult,
pubmed-meshheading:18945747-Aged,
pubmed-meshheading:18945747-Antibodies, Monoclonal,
pubmed-meshheading:18945747-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:18945747-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18945747-Cisplatin,
pubmed-meshheading:18945747-Cytarabine,
pubmed-meshheading:18945747-Dexamethasone,
pubmed-meshheading:18945747-Etoposide,
pubmed-meshheading:18945747-Humans,
pubmed-meshheading:18945747-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:18945747-Middle Aged,
pubmed-meshheading:18945747-Retrospective Studies,
pubmed-meshheading:18945747-Salvage Therapy,
pubmed-meshheading:18945747-Treatment Outcome,
pubmed-meshheading:18945747-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
|
|
pubmed:affiliation |
Department of Hematology, Complejo Hospitalario de Zamora, Avenida de Requejo 35, Zamora 49022, Spain. amartingar@aehh.org
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
